Factorial Energy's SPAC merger saw 84% of public shareholders take $10.42 cash, leaving 40M-45M shares as "free float" for ...
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no ...
RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has decreased $0.27 since the market last closed. This is a 9.93 ...
FAC is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of FAC shares has decreased $0.33 since the market last closed. This is a 8.78% ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results